Loading...

Darktrace plc

DARK.L•LSE
Technology
Software - Infrastructure
£576.80
£0.40(0.07%)

Darktrace plc (DARK.L) Stock Overview

Explore Darktrace plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.7/100

Key Financials

Market Cap3.7B
P/E Ratio92.08
EPS (TTM)$0.13
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$735.34

DARK.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Darktrace plc (DARK.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $735.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 92.08 and a market capitalization of 3.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for DARK.LStats details for DARK.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for DARK.LAnalyst Recommendations details for DARK.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Darktrace plc, together with its subsidiaries, engages in the development and sale of cyber-threat defense technology solutions in the United Kingdom, the United States, Canada, Europe, and internationally. Its products include Enterprise Immune System to discover unpredictable cyber-threats; Industrial Immune System to detect novel threats and vulnerabilities, as well as safeguard the integrity and resilience of industrial technologies; and Cyber AI Analyst, an AI investigation technology, which automatically triages, interprets, and reports scope of security incidents. The company also provides Darktrace Antigena, an autonomous response technology for the enterprise with various security products that delivers proactive cyber defense to digital infrastructure. It serves critical national infrastructure organizations, financial services companies, technology and healthcare providers, media corporations, and educational institutions. The company was founded in 2013 and is headquartered in Cambridge, the United Kingdom.

CEO

Jill Popelka

Employees

2,300

Headquarters

Maurice Wilkes Building, Cambridge

Founded

2021

Frequently Asked Questions

;